Abstract:
The present application relates to a new silane-based compound, a photosensitive resin composition including the same, and a photosensitive material including the same. The photosensitive resin composition including the silane-based compound according to the exemplary embodiment of the present application increases adhesion strength to a substrate, such that a developing property is excellent and there are no surface stains or defects during a subsequent process. Accordingly, a photosensitive material, a color filter and the like having excellent quality may be manufactured by using the photosensitive resin composition according to the exemplary embodiment of the present application.
Abstract:
A solar cell module is provided. The solar cell module includes: a substrate; a plurality of unit cells including a first electrode, a semiconductor layer, and a second electrode that are sequentially deposited on the substrate; a first sub-module and a second sub-module having the unit cells, respectively; a first longitudinal pattern dividing the unit cells of the first sub-module, and a second longitudinal pattern dividing the unit cells of the second sub-module; a transverse pattern dividing the first sub-module and the second sub-module; and an insulating portion disposed near the transverse pattern, and insulating between the first sub-module and the second sub-module, wherein the unit cells of the first sub-module are connected in series through the first longitudinal pattern, the unit cells of the second sub-module are connected in series through the second longitudinal pattern, and the first sub-module and the second sub-module are connected in series through the transverse pattern.
Abstract:
Disclosed herein is a recombinant Escherichia coli (E. coli) capable of producing D-xylonic acid from D-xylose and a method for producing D-xylonic acid using the same. The recombinant E. coli producing D-xylonic acid from D-xylose according to the present invention is a recombinant E. coli EWX4 (Microorganism deposition number KCTC11988BP) capable of producing D-xylonic acid from D-xylose. When utilizing the recombinant E. coli prepared by the method of the present invention, it is possible to produce D-xylonic acid from D-xylose with high yield while reducing production cost using sole carbon source.
Abstract:
A silicon-based hardmask composition, including an organosilane polymer represented by Formula 1: {(SiO1.5—Y—SiO1.5)x(R3SiO1.5)y(XSiO1.5)z}(OH)e(OR6)f (1).
Abstract:
A Foley catheter assembly is disclosed. The Foley catheter assembly includes a Foley catheter, which includes an insertion tip inserted into the bladder and a drainage tube extending from the insertion tip and draining urine from the bladder, and a catheter support cover, which covers the outer surface of the Foley catheter before insertion of the Foley catheter into the bladder to prevent contamination and allows smooth insertion of the insertion tip into the bladder at a constant speed. The catheter support cover includes a pair of support main bodies that are detachably coupled to each other and accommodate the drainage tube and a pair of transport rollers disposed at both sides of the insertion tip at upper portions of the support main bodies to be rotatable for inserting the insertion tip into the bladder.
Abstract:
In one aspect, the present disclosure relates to a method of processing a thin film including, while advancing a thin film in a first selected direction, irradiating a first region of the thin film with a first laser pulse and a second laser pulse, each laser pulse providing a shaped beam and having a fluence that is sufficient to partially melt the thin film and the first region re-solidifying and crystallizing to form a first crystallized region, and irradiating a second region of the thin film with a third laser pulse and a fourth laser pulse, each pulse providing a shaped beam and having a fluence that is sufficient to partially melt the thin film and the second region re-solidifying and crystallizing to form a second crystallized region, wherein the time interval between the first laser pulse and the second laser pulse is less than half the time interval between the first laser pulse and the third laser pulse.
Abstract:
A controlled-release pharmaceutical composition including first and second groups of microparticles, each of the microparticles including a core including tamsulosin or pharmaceutically acceptable salts thereof, a controlled-release polymer coating layer formed on the core, and an enteric polymer outer layer formed on the controlled-release polymer coating layer, wherein the average thickness of the controlled-release polymer coating layer is different in each of the first and second groups of microparticles, and an oral formulation including the same, are provided. This pharmaceutical composition can easily control the extent of release of an active ingredient depending on changes in pH in the intestinal tract and the release pattern of the active ingredient in the small intestine, thus preventing the active ingredient from being rapidly transferred into the blood to thereby minimize side-effects, and maintaining the effective blood concentration of the active ingredient for a predetermined period of time. Furthermore, this composition can shield the bitter taste of the active ingredient even when exposed to the inside of the mouth, thus increasing the therapeutic effects for patients upon oral administration.
Abstract:
Systems, methods, and computer-readable media for communicating advertisement preferences configured by users to a plurality of network domains that serve advertisements are provided. Users input their preferences with respect to advertisement targeting through a common interface and those preferences are communicated to a plurality of network domains in conjunction with requests for advertisements. In this way, users do not have to submit their preferences for advertisement targeting independently for each network domain that serves advertisements and advertisement-serving network domains have a decreased risk of having outdated or incomplete advertisement targeting information.
Abstract:
An apparatus for managing radiation doses is provided. The apparatus includes an information extraction unit configured to extract information about a patient to be examined, information about an image acquired by examining a bodily region of the patient using a radiographic apparatus, and information about the examination performed by the radiographic apparatus, a radiation dose calculation unit configured to calculate, using the image information, an effective dose generated by the radiographic apparatus when acquiring the image, and a dose data storage unit configured to store effective dose data in a database, the effective dose data including the calculated effective dose, the patient information, and the examination information.
Abstract:
The present invention relates to pyrazolylmethylamine-piperazine derivatives and their pharmaceutically acceptable salts effective as calcium channel modulators and a method of manufacturing the same. The present invention also relates to the medicinal use of the above compounds as therapeutic treatment of diseases due to their effect as calcium channel modulators.